May Griffith, PhD, University of Montreal & Hopital Maisonneuve-Rosemont, Montreal, Canada, outlines the significance of regenerative medicine within the field of ophthalmology. Stem cells have the potential to stimulate growth within the eye, and research in corneal regeneration can reduce the need for corneal transplants. Prof. Griffith additionally highlights the potential applications of the technology in other organ systems. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).
Prof. Griffith is a named inventor on PCT patents WO2007/028258 A2 Interpenetrating networks, and related methods and compositions, assigned to the Ottawa Hospital Research Institute and University of Ottawa; PCT/IB2017/056342 Collagen and CLP-based hydrogels, corneal implants, filler glue and uses thereof, which was assigned to the Hyderabad Eye Research Foundation, and then subsequently assigned to North Grove Investments, Inc. wherein PCT national phase applications have been filed in the USA, EU, India, China, and Canada. She is also a named inventors on a US provisional patent application no. 62916765, subsequent to a disclosure to Maisonneuve-Rosemont Hospital and Université de Montréal.